Signs, Symptoms, and Look-Alike Conditions
At a Glance
FPLD4 is an inherited fat-storage disorder in which fat is lost from the arms, legs, and buttocks but builds up around organs such as the liver. This pattern can cause insulin resistance and high triglycerides and may be mistaken for PCOS, metabolic syndrome, or Cushing syndrome.
Because Familial Partial Lipodystrophy type 4 (FPLD4) is so rare, its symptoms are frequently mistaken for more common conditions. Most people with FPLD4 do not look “thin”; instead, they have a unique distribution of fat that can be confusing to both patients and doctors. Understanding the specific physical and metabolic signs of FPLD4 can help you navigate your diagnosis and explain your symptoms to your care team.
The Timing of Body Changes
Unlike some genetic conditions that are obvious at birth, FPLD4 is a condition that often becomes apparent around puberty or adulthood [1]. This means that during childhood, your body may appear entirely typical, and a normal childhood appearance does not rule out the condition. The hallmark fat loss (lipoatrophy) usually begins during or shortly after puberty [1][2].
As the body grows, the mutated PLIN1 gene (which is present from birth) interferes with how fat is stored. You may notice that fat seems to “melt away” from specific areas while accumulating in others. This transition can be a distressing time, as the body begins to look vastly different from one’s peers.
Core Physical Symptoms
The physical appearance of FPLD4 is often described as “partial” because fat is lost in some places but preserved or even increased in others.
- Partial Lipoatrophy: The most common pattern is a loss of fat from the limbs (arms and legs) and the gluteal (buttock) region [1]. This loss of cushioning can make sitting for long periods uncomfortable and can give the limbs a very lean appearance.
- Muscular Appearance: Because there is very little fat covering the muscles, they appear unusually large and defined, mimicking muscular hypertrophy [1]. You may look like an athlete or bodybuilder without ever setting foot in a gym. This “pseudo-muscular” look is often accompanied by prominent, visible superficial veins on the arms and legs [1].
- Acromegaloid Features: Some individuals develop “coarse” facial features, such as a prominent jaw or larger hands and feet, though this is uncommon or phenotype-dependent [1].
- Hirsutism: Women with FPLD4 may experience excess hair growth on the face or body [1]. This is usually a secondary effect of the severe insulin resistance that often accompanies the condition [2].
The “Spillover” Effect: Ectopic Fat
Because the fat cells under your skin cannot hold onto lipids, the fat must go somewhere else. It begins to accumulate in organs and tissues that are not meant to store it—a process called ectopic fat deposition [3].
This “spillover” primarily affects the liver and the blood. Many patients develop hepatic steatosis (fatty liver). Normal liver enzymes on a blood test do not exclude this; imaging and validated fibrosis assessments are often used alongside laboratory tests to evaluate liver health [1][2]. Additionally, the blood can become overloaded with fats, leading to severe hypertriglyceridemia (very high triglycerides) [4]. In some cases, triglycerides can reach levels high enough to cause a milky appearance in the blood and increase the risk of inflammation in the pancreas [5].
Look-Alike Conditions and Misdiagnosis
FPLD4 is a “great imitator.” Because its symptoms overlap with common metabolic problems, many patients are misdiagnosed for years.
Polycystic Ovary Syndrome (PCOS)
Many women with FPLD4 are first told they have PCOS. Both conditions involve irregular periods, hirsutism, and insulin resistance [1][2]. While these conditions can theoretically coexist, PCOS is a hormonal disorder primarily involving the ovaries, while FPLD4 is a fat-storage disorder. If you have “PCOS symptoms” alongside very lean arms and legs, it is a significant clue that a lipodystrophy screening may be necessary.
Typical Metabolic Syndrome and Obesity
FPLD4 can look like “typical” metabolic syndrome because of the presence of diabetes, high blood pressure, and high triglycerides [6]. However, there is a key difference: in typical metabolic syndrome, fat is usually present under the skin throughout the body. In FPLD4, there is a stark contrast between the lack of fat on the limbs and the presence of fat around the internal organs or the neck [1].
Cushing Syndrome
In rare cases, FPLD4 is mistaken for Cushing syndrome (excess cortisol). Both can cause fat to accumulate around the face and neck (“moon face” or “buffalo hump”) while limbs remain thin [7]. The clinical pattern may prompt evaluation for both conditions, and genetic testing for PLIN1 is not a substitute for proper endocrine testing for cortisol when Cushing syndrome is suspected [1].
Understanding that these “look-alike” conditions exist can help you advocate for the correct testing. If your “metabolic syndrome” seems unusual because of your muscularity or specific fat-loss patterns, discussing FPLD4 with a specialist is an important next step.
Common questions in this guide
What are the main physical signs of FPLD4?
When do FPLD4 symptoms usually begin?
Can FPLD4 be mistaken for PCOS?
Why can someone with FPLD4 look muscular without strength training?
What do fatty liver and high triglycerides mean in FPLD4?
How is FPLD4 distinguished from Cushing syndrome?
Get notified when new evidence is published on PLIN1-related familial partial lipodystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy.
Jéru I, Vantyghem MC, Bismuth E, et al.
The Journal of clinical endocrinology and metabolism 2019; (104(12)):6025-6032 doi:10.1210/jc.2019-00849.
PMID: 31504636 - 2
The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature.
Chen RX, Zhang L, Ye W, et al.
BMC nephrology 2018; (19(1)):111 doi:10.1186/s12882-018-0913-6.
PMID: 29747582 - 3
Familial Partial Lipodystrophy (FPLD): Recent Insights.
Bagias C, Xiarchou A, Bargiota A, Tigas S
Diabetes, metabolic syndrome and obesity : targets and therapy 2020; (13()):1531-1544 doi:10.2147/DMSO.S206053.
PMID: 32440182 - 4
Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy.
Vergès B, Vantyghem MC, Reznik Y, et al.
Arteriosclerosis, thrombosis, and vascular biology 2024; (44(8)):1873-1883 doi:10.1161/ATVBAHA.124.320774.
PMID: 38899472 - 5
Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen.
Jadrníčková P, Tichý L, Kašpráková M, et al.
Journal of clinical lipidology 2026; (20(2)):444-450 doi:10.1016/j.jacl.2025.11.016.
PMID: 41513480 - 6
Lipodystrophies: adipose tissue disorders with severe metabolic implications.
Cortés VA, Fernández-Galilea M
Journal of physiology and biochemistry 2015; (71(3)):471-8 doi:10.1007/s13105-015-0404-1.
PMID: 25833179 - 7
An adolescent girl referred with Cushing syndrome--does she or does she not have the syndrome?
Kao KT, Zacharin M
Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(1)):109-12.
PMID: 26677885
This page is for informational purposes only and does not constitute medical advice about FPLD4. An endocrinologist or genetics specialist can help interpret your symptoms, examination, and test results.